Langhorne, PA, United States of America

C Mark Eppler


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of C Mark Eppler

Introduction

C Mark Eppler is an accomplished inventor based in Langhorne, Pennsylvania, known for his significant contributions to the field of biotechnology. Holding one patent, he focuses on innovative methods that enhance our understanding of the human body, particularly in relation to opioid receptors.

Latest Patents

Eppler's patented invention is a method for detecting the expression of proteins closely related to opioids. His patent provides isolated DNAs encoding opiorph receptor polypeptides, which are crucial for medical research and treatment developments. The invention includes recombinant cloning vectors containing these DNA sequences, as well as cells that integrate these vectors. Furthermore, the patent outlines methods for detecting the expression of mRNA, which encodes the respective polypeptides, and for producing these valuable proteins. Notably, the patent also encompasses isolated polypeptides and antibodies directed against these polypeptides, showcasing its potential for clinical applications.

Career Highlights

C Mark Eppler is associated with American Cyanamid Company, where he has applied his expertise in biopharmaceuticals. His innovative work in biotechnology not only reflects his skill as an inventor but also demonstrates his commitment to advancing medical science through research and development.

Collaborations

Throughout his career, Eppler has collaborated with talented individuals in the field, including colleagues like Bradley Alton Ozenberger and Jeffrey David Hulmes. Together, they contribute to a vibrant research environment that fosters innovation and discovery in the realm of biotechnology.

Conclusion

C Mark Eppler exemplifies the spirit of innovation in the life sciences. His patented methods for detecting opioid-related proteins have the potential to improve our understanding and treatment of opioid-related conditions. With continued collaboration and dedication, Eppler stands as a testament to the impactful role inventors play in advancing medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…